Crossover Study May Show Dose Response For Inhaled Steroids - FDA Cmte.
A crossover study may be one way to show dose response in bioequivalence studies for inhaled corticosteroids, members of the Orally Inhaled & Nasal Drugs Subcommittee of FDA's Pharmaceutical Sciences Advisory Committee agreed at a recent meeting.
You may also be interested in...
Muro Pharmaceuticals is increasing production to launch its Tri-Nasal intranasal steroid medication by the start of the fall allergy season.
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011